Journal
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume 48, Issue 6, Pages 769-774Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/CCLM.2010.157
Keywords
chronic kidney disease; clinical guidelines; dialysis; parathyroid hormone; reference values
Categories
Ask authors/readers for more resources
The Kidney Disease: Improving Global Outcomes (KDIGO) have recently replaced the K/DOQI guidelines to help nephrologists in diagnosing, treating and monitoring chronic kidney disease mineral and bone disorders (CKD-MBD). Here, we comment on the KDIGO recommendations concerning the interpretation of parathyroid hormone (PTH) concentrations in dialysis patients: In patients with CKD stage 5D, we suggest maintaining iPTH in the range of approximately two to nine times the upper normal limit of the assay. We suggest that marked changes in PTH concentrations in either direction within this range prompt an initiation or change in therapy to avoid progression to concentrations outside of this range''. Our comments concern the interpretation of PTH in dialysis patients, but also the more global problem of establishing normal values for PTH. Clin Chem Lab Med 2010;48:769-74.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available